Concepts (109)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Extracellular Matrix | 3 | 2021 | 130 | 1.560 |
Why?
|
| Versicans | 4 | 2021 | 6 | 1.500 |
Why?
|
| ADAMTS9 Protein | 5 | 2019 | 5 | 1.240 |
Why?
|
| ADAM Proteins | 2 | 2015 | 35 | 0.930 |
Why?
|
| Matrix Metalloproteinase 14 | 1 | 2023 | 3 | 0.870 |
Why?
|
| Cadherins | 4 | 2012 | 67 | 0.870 |
Why?
|
| Hemopexin | 1 | 2023 | 5 | 0.870 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2021 | 15 | 0.740 |
Why?
|
| Actins | 4 | 2012 | 259 | 0.730 |
Why?
|
| Xenopus | 2 | 2012 | 54 | 0.730 |
Why?
|
| Umbilical Arteries | 1 | 2020 | 9 | 0.720 |
Why?
|
| Mouse Embryonic Stem Cells | 1 | 2021 | 22 | 0.720 |
Why?
|
| Aggrecans | 1 | 2020 | 9 | 0.720 |
Why?
|
| Hyaluronic Acid | 1 | 2021 | 63 | 0.700 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2020 | 60 | 0.690 |
Why?
|
| ADAMTS Proteins | 1 | 2019 | 3 | 0.650 |
Why?
|
| Cilia | 2 | 2019 | 156 | 0.610 |
Why?
|
| Proteolysis | 5 | 2023 | 137 | 0.520 |
Why?
|
| Umbilical Cord | 1 | 2015 | 9 | 0.500 |
Why?
|
| Embryonic Development | 2 | 2014 | 136 | 0.500 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2015 | 47 | 0.490 |
Why?
|
| Neural Crest | 1 | 2014 | 29 | 0.450 |
Why?
|
| Mice, Transgenic | 4 | 2020 | 1220 | 0.450 |
Why?
|
| Biological Evolution | 1 | 2014 | 109 | 0.420 |
Why?
|
| Membrane Proteins | 2 | 2021 | 843 | 0.390 |
Why?
|
| Morphogenesis | 2 | 2010 | 112 | 0.330 |
Why?
|
| Cell Differentiation | 3 | 2021 | 1295 | 0.330 |
Why?
|
| Ectoderm | 1 | 2009 | 12 | 0.330 |
Why?
|
| Animals | 13 | 2021 | 19595 | 0.320 |
Why?
|
| Mice | 7 | 2021 | 10249 | 0.270 |
Why?
|
| Mutation | 3 | 2019 | 2425 | 0.260 |
Why?
|
| Cells, Cultured | 3 | 2021 | 2102 | 0.250 |
Why?
|
| Cell Adhesion Molecules | 3 | 2010 | 90 | 0.230 |
Why?
|
| Cell Membrane | 2 | 2023 | 489 | 0.190 |
Why?
|
| Models, Biological | 2 | 2019 | 1138 | 0.190 |
Why?
|
| Stem Cell Niche | 1 | 2021 | 12 | 0.180 |
Why?
|
| ADAMTS1 Protein | 1 | 2020 | 1 | 0.180 |
Why?
|
| Hematopoiesis | 1 | 2021 | 123 | 0.180 |
Why?
|
| Parturition | 1 | 2020 | 53 | 0.170 |
Why?
|
| Hedgehog Proteins | 1 | 2021 | 113 | 0.170 |
Why?
|
| Up-Regulation | 1 | 2021 | 363 | 0.170 |
Why?
|
| Peptides | 1 | 2023 | 548 | 0.170 |
Why?
|
| Protein Aggregates | 1 | 2019 | 18 | 0.160 |
Why?
|
| Yolk Sac | 1 | 2019 | 5 | 0.160 |
Why?
|
| Fibronectins | 1 | 2019 | 43 | 0.160 |
Why?
|
| Neural Tube Defects | 1 | 2019 | 27 | 0.160 |
Why?
|
| Ciliopathies | 1 | 2019 | 10 | 0.160 |
Why?
|
| Polycystic Kidney Diseases | 1 | 2019 | 17 | 0.160 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2019 | 103 | 0.160 |
Why?
|
| Xenopus laevis | 2 | 2010 | 66 | 0.160 |
Why?
|
| Gene Knockout Techniques | 1 | 2019 | 89 | 0.160 |
Why?
|
| Embryo, Mammalian | 2 | 2019 | 161 | 0.150 |
Why?
|
| Endocytosis | 1 | 2019 | 148 | 0.150 |
Why?
|
| Signal Transduction | 3 | 2019 | 2885 | 0.150 |
Why?
|
| Embryonic Stem Cells | 2 | 2016 | 150 | 0.150 |
Why?
|
| Stromal Cells | 1 | 2017 | 65 | 0.150 |
Why?
|
| Fibroblasts | 1 | 2019 | 367 | 0.140 |
Why?
|
| Cell Line | 2 | 2019 | 2014 | 0.140 |
Why?
|
| Neovascularization, Pathologic | 1 | 2017 | 138 | 0.140 |
Why?
|
| CRISPR-Cas Systems | 1 | 2021 | 323 | 0.140 |
Why?
|
| Fucosyltransferases | 1 | 2016 | 4 | 0.140 |
Why?
|
| Mice, Knockout | 2 | 2019 | 1987 | 0.130 |
Why?
|
| Gastrulation | 1 | 2016 | 16 | 0.130 |
Why?
|
| Embryo, Nonmammalian | 3 | 2010 | 170 | 0.120 |
Why?
|
| Palate | 1 | 2014 | 9 | 0.110 |
Why?
|
| Extremities | 1 | 2014 | 50 | 0.110 |
Why?
|
| Pregnancy | 1 | 2020 | 2352 | 0.110 |
Why?
|
| Humans | 6 | 2023 | 59281 | 0.100 |
Why?
|
| Female | 5 | 2020 | 30797 | 0.100 |
Why?
|
| Cell Movement | 1 | 2014 | 422 | 0.100 |
Why?
|
| Heart | 1 | 2014 | 274 | 0.100 |
Why?
|
| Neural Tube | 1 | 2010 | 11 | 0.090 |
Why?
|
| Neural Plate | 1 | 2009 | 1 | 0.080 |
Why?
|
| Epidermis | 1 | 2009 | 37 | 0.080 |
Why?
|
| Substrate Specificity | 1 | 2009 | 321 | 0.070 |
Why?
|
| Myosins | 1 | 2009 | 109 | 0.070 |
Why?
|
| Cytoplasm | 1 | 2009 | 272 | 0.070 |
Why?
|
| Xenopus Proteins | 1 | 2007 | 34 | 0.070 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2007 | 127 | 0.070 |
Why?
|
| Phosphoproteins | 1 | 2007 | 216 | 0.060 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2009 | 630 | 0.060 |
Why?
|
| Male | 3 | 2019 | 27479 | 0.050 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2019 | 65 | 0.040 |
Why?
|
| Retinal Pigment Epithelium | 1 | 2019 | 26 | 0.040 |
Why?
|
| Spheroids, Cellular | 1 | 2019 | 26 | 0.040 |
Why?
|
| Zebrafish Proteins | 1 | 2019 | 150 | 0.040 |
Why?
|
| Neoplasm Metastasis | 1 | 2017 | 196 | 0.030 |
Why?
|
| Tumor Microenvironment | 1 | 2017 | 141 | 0.030 |
Why?
|
| Amnion | 1 | 2016 | 9 | 0.030 |
Why?
|
| Mesoderm | 1 | 2016 | 83 | 0.030 |
Why?
|
| Body Patterning | 1 | 2016 | 85 | 0.030 |
Why?
|
| Zebrafish | 1 | 2019 | 323 | 0.030 |
Why?
|
| Phenotype | 1 | 2019 | 1155 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 484 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2016 | 571 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 1369 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2017 | 943 | 0.030 |
Why?
|
| Macrophages | 1 | 2017 | 1004 | 0.020 |
Why?
|
| Nectins | 1 | 2010 | 2 | 0.020 |
Why?
|
| Immunoglobulins | 1 | 2010 | 76 | 0.020 |
Why?
|
| DNA Primers | 1 | 2010 | 291 | 0.020 |
Why?
|
| Microfilament Proteins | 1 | 2010 | 116 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2010 | 294 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2016 | 3185 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 525 | 0.020 |
Why?
|
| Blastula | 1 | 2007 | 4 | 0.020 |
Why?
|
| Receptors, Lysophosphatidic Acid | 1 | 2007 | 3 | 0.020 |
Why?
|
| Catenins | 1 | 2007 | 9 | 0.020 |
Why?
|
| Base Sequence | 1 | 2010 | 1311 | 0.020 |
Why?
|